FIELD: organic chemistry, medicine, oncology, pharmacy. SUBSTANCE: invention relates to novel fluoro-derivative of 1,3,5-oxadiazine eliciting the expressed antitumor effect relative to breast adenocarcinoma cells. Invention describes 2,2,6,6-tetrakis-(trifluoromethyl)-4-ethylamino-5,6-dihydro-1,3,5-oxadiazine of the formula: 
. Invention proposes also method of its synthesis and pharmaceutical composition based on thereof. Invention provides preparing the novel compound eliciting valuable biological properties. EFFECT: improved method of synthesis, valuable medicinal properties. 3 cl, 1 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| 4-NITRO-3-FLUOROMETHYLPERFLUORONONANOYLANILIDE (FLUSTAT), METHOD IF ITS SYNTHESIS AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2001 |
|
RU2186057C1 |
| CONJUGATE OF BIOLOGICALLY ACTIVE SUBSTANCES WITH $$$-FETOPROTEIN SHOWING THE SELECTIVE ACTION WITH RESPECT TO CANCER TUMORS, METHOD OF THEIR PREPARING (VARIANTS) AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 1996 |
|
RU2071351C1 |
| PEPTIDE REPRESENTING ANALOG OF ALPHA-FETOPROTEIN FRAGMENT, CONJUGATE OF PEPTIDE WITH DOXORUBICIN AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF FOR TREATMENT OF ONCOLOGY DISEASE | 2006 |
|
RU2317102C1 |
| POLYMER CONTAINING MEDICINAL AGENT BASED ON ANTITUMOR AGENT ETOPOSIDE | 2015 |
|
RU2595859C1 |
| MODULATOR OF CELLULAR IMMUNITY | 1997 |
|
RU2146528C1 |
| BICYCLIC HETEROCYCLIC COMPOUNDS AND THEIR APPLICATIONS | 2020 |
|
RU2811612C2 |
| ACRYLANILIDE DERIVATIVE, A METHOD FOR PRODUCTION THEREOF AND USE THEREOF IN PHARMACOLOGY | 2016 |
|
RU2742372C2 |
| IMIDAZOPYRIDINE IAP INHIBITORS | 2007 |
|
RU2466131C2 |
| DERIVATIVES OF ANTHRANILIC ACID, METHODS OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 1997 |
|
RU2195454C2 |
| EP4 ANTAGONISTS | 2016 |
|
RU2761341C2 |
